Search This Blog

Wednesday, August 5, 2026

Orthofix ups guidance

 

Orthofix Medical posts Q2 2026 revenue $210.9M, adjusted EPS $0.07, GAAP loss $0.39, raises 2026 sales and EBITDA guidance

  • Revenue of $210.9 million slightly exceeded the $209.5 million sales forecast from Zacks-surveyed analysts.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)